CN103070995A - Traditional Chinese medicine for curing prostatitis - Google Patents
Traditional Chinese medicine for curing prostatitis Download PDFInfo
- Publication number
- CN103070995A CN103070995A CN2012105971563A CN201210597156A CN103070995A CN 103070995 A CN103070995 A CN 103070995A CN 2012105971563 A CN2012105971563 A CN 2012105971563A CN 201210597156 A CN201210597156 A CN 201210597156A CN 103070995 A CN103070995 A CN 103070995A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- herba
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for curing prostatitis. The traditional Chinese medicine is composed of the following herb components in part by weight: 14 to 26 parts of the root of red-rooted salvia, 9 to 21 parts of root of common peony, 9 to 21 parts of herba lycopi, 6 to 18 parts of peach kernel, 9 to 21 parts of fennel, 9 to 21 parts of Chinese angelica, 3 to 15 parts of rhizoma alismatis, 6 to 18 parts of radix rehmanniae recen, 14 to 26 parts of isatis root, 14 to 26 parts of ixeris chinensis and 14 to 26 parts of dandelion. The components of the traditional Chinese medicine are common pure traditional Chinese medicine a, have reasonable compatibility, and have low toxic and side effect; moreover, the traditional Chinese medicine has an obvious curative effect in curing male prostatitis.
Description
Technical field
The invention belongs to the Chinese medicine technical field, especially a kind ofly treat prostatitic Chinese medicine.
Background technology
The prostatitis traditional Chinese medical science is commonly called as smart turbid, is a kind of common andropathy, generally is divided into acute and chronic two types.The chronic prostatitis clinical manifestation differs greatly, the symptom of urinating is in various degree arranged mostly: such as dysurea, urgent micturition, frequent micturition, frequent urination at night etc., some patient urinates the mucus that white can be flowed out in the end, and has sense of discomfort or pain in perineum, crissum, the upper and lower abdominal part of pubis, groin, scrotum, femoribus internus and testis, the urethra.Idol has the rear pain of ejaculation, premature ejaculation, sexual impotence or hemospermia.
Doctor trained in Western medicine is used antimicrobial drug such as Roxithromycin, quinolones mostly, and the treatments such as pervasive Thailand, tamsulosin hydrochloride, terazosin hydrochloride, and curative effect is relatively poor, and side effect is large, and relapse rate is high.
Mainly be divided into following several types on the tcm clinical practice: lower warmer wetness-heat type, qi stagnation and blood stasis type, damp abundance due to splenic asthenia type, liver-kidney yin deficiency, the deficiency of kidney essence type uses treatment by Chinese herbs, and drug effect is gentle, and side effect is little, and cure rate is high.
Prostatosis brings the very large misery of patient and radical cure is difficult.Therefore, need the prostatitic Chinese medicine of a kind of new treatment with better treatment male prostatitis.
Summary of the invention
In view of this, the present invention is devoted to better to cure male prostatitis, has proposed a kind of prostatitic Chinese medicine for the treatment of.
According to technical scheme of the present invention, provide a kind of prostatitic Chinese medicine for the treatment of.This is treated prostatitic Chinese medicine and is comprised of the Chinese medicinal components that following weight ratio forms:
Radix Salviae Miltiorrhizae 14-26 part, Radix Paeoniae Rubra 9-21 part, Herba Lycopi 9-21 part, Semen Persicae 6-18 part, Fructus Foeniculi 9-21 part, Radix Angelicae Sinensis 9-21 part, Rhizoma Alismatis 3-15 part, Radix Rehmanniae 6-18 part, Radix Isatidis 14-26 part, Herba Ixeritis chinensis 14-26 part, Herba Taraxaci 14-26 part.
Be preferably:
20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Radix Paeoniae Rubra, 15 parts of Herba Lycopi, 12 parts in Semen Persicae, 15 parts of Fructus Foeniculi, 15 parts of Radix Angelicae Sinensis, 9 parts of Rhizoma Alismatis, 12 parts of Radix Rehmanniae, 20 parts of Radix Isatidis, 20 parts of Herba Ixeritis chinensiss, 20 parts of Herba Taraxacis.
Among the present invention:
Radix Salviae Miltiorrhizae: effect, promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Meridian distribution of property and flavor, hardship is slightly cold, and enters the heart, Liver Channel.
Radix Paeoniae Rubra: effect, clearing away heat and cooling blood, eliminating stasis to stop pain.Be used for maculae caused by violent heat pathogen, hematemesis and epistaxis, conjunctival congestion and swelling pain, hypochondriac pain due to stagnation of liverQI, amenorrhea dysmenorrhea, lump in the abdomen stomachache, injury from falling down, carbuncle skin infection; Meridian distribution of property and flavor, hardship is slightly cold, and returns Liver Channel.
The Herba Lycopi: function cures mainly, blood circulation promoting and blood stasis dispelling, line water detumescence.Be used for menoxenia, amenorrhea, dysmenorrhea, postnatal blood stasis stomachache, edema; Meridian distribution of property and flavor, bitter, hot, tepor is returned liver, spleen channel.
Semen Persicae: function cures mainly, blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, relieving cough and asthma.Be used for amenorrhea, dysmenorrhea, injury from falling down, dryness of the intestine constipation; Meridian distribution of property and flavor, bitter, sweet, flat, GUIXIN, liver, large intestine channel.
Fructus Foeniculi: effect and effect, dispersing cold for relieving pain, regulating qi-flowing for harmonizing stomach; Be used for colic of cold type stomachache, the testis swelling and hanging down of either of the testes, dysmenorrhea, few abdomen cold type of pain, abdominal distention, lack of appetite and vomiting, hydrocele of testis.
Radix Angelicae Sinensis: cure mainly, all cards of blood deficiency, menoxenia, amenorrhea, dysmenorrhea, the lump in the abdomen knot is poly-, metrorrhagia, asthenia cold abdominalgia, flaccidity syndrome and arthralgia syndrome, numbness of the skin, the dryness of the intestine dyschezia, heavy after the bloody dysentery, ulcer sores, injury from falling down; Meridian distribution of property and flavor, sweet in the mouth, suffering, hardship, warm in nature, return liver, the heart, spleen channel.
Rhizoma Alismatis: function cures mainly, promoting diuresis to eliminate damp pathogen, and it is treating stranguria to expel the heat-evil, main dysuria, the puckery pain of pyretic stranguria, the edema distension is had loose bowels, dizziness due to fluid-retention, seminal emission; Meridian distribution of property and flavor, sweet in the mouth, light, cold in nature, return kidney, urinary bladder channel.
Radix Rehmanniae: function cures mainly, heat clearing away, promote the production of body fluid, moisturize, laxation, removing blood stasis with potent drugs, tissue regeneration promoting, pain relieving, regulating menstruation, the incised wound stasis of blood, removing heat from blood, hemostasis; Meridian distribution of property and flavor, sweet, cold, GUIXIN, liver, kidney channel.
Radix Isatidis: function cures mainly, maculae caused by violent heat pathogen, high heat headache, major part pestilence, crimson tongue is purple dark, scarlet fever, erysipelas, mumps, sore throat, skin ulcer is swollen, carbuncle, chickenpox, measles, hepatitis, influenza, epidemic encephalitis, encephalitis b, pneumonia, coma is told nosebleed, pharyngeal swelling, acute catarrhal conjunctivitis, the skin ulcer rash can be prevented and treated epidemic encephalitis type B, acute, chronic hepatitis, mumps, osteomyelitis; Meridian distribution of property and flavor enters liver, stomach blood system, returns liver; The stomach warp.
Herba Ixeritis chinensis: function cures mainly, and is used for acute appendicitis, and the high heat of lung abscess is coughed vomiting bloody pus, pyretic toxicity skin ulcer furuncle, and furuncle is bitterly swollen, breast abdomen pain, appendicitis, enteritis, dysentery, puerperal abdonimal pain, dysmenorrhea; Meridian distribution of property and flavor, acrid in the mouth, hardship are slightly cold, and return liver, stomach, large intestine channel.
Herba Taraxaci: function cures mainly, diuresis, cathartic, jaundice eliminating subcutaneous ulcer, function of gallbladder promoting, respiratory tract infection, eye conjunctivitis, mumps, hyperglycemia, acute mastitis swells and ache, gastritis, dysentery, hepatitis, gallbladder is assisted inflammation, acute appendicitis, urinary system infection, pelvic inflammatory disease, carbuncle furuncle furuncle, pharyngitis is controlled the acute inflammation of assisting, acute appendicitis, urinary system infection, pelvic inflammatory disease, carbuncle furuncle furuncle, pharyngitis is controlled acute mastitis, lymphadenitis, scrofula, furuncle carbuncle toxin, acute conjunctivitis, cold, fever, acute tonsillitis, acute bronchitis, urinary tract infection; Meridian distribution of property and flavor, sweet, little hardship, cold, heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.
Chinese medicine of the present invention has blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, tonifying kidney-yin, the effect of eliminating dampness and diuresis; Curing mainly to be retarded by silt, to swell and ache is few abdomen diseases of primary symptom, and male prostatitis is had good curative effect.
Dosage form of the present invention comprises tablet, oral liquid, capsule, granule, electuary and pill.
Preferred dosage form is oral liquid.
Manufacture method:
Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Herba Lycopi, Semen Persicae, Fructus Foeniculi, Radix Angelicae Sinensis, Rhizoma Alismatis, Radix Rehmanniae, Radix Isatidis, Herba Ixeritis chinensis and the Herba Taraxaci 11 flavor medicines of constant weight proportioning are cleaned up, soaked 15 minutes to 30 minutes, decoct with high heat before the not boiling, after boiling, use again slow fire boiling instead, and remain on slight boiling condition, decoct altogether twice, each amount of water was not to have powder to be advisable, merge decocting liquid twice, filter gained filtrate, be concentrated into relative density under 80 ℃ the condition and be 1.12～1.15 clear paste, i.e. the active component of medicine of the present invention.Required various conventional adjuvant when this active component is added preparation different dosage form is made a kind of getting final product in tablet, oral liquid, capsule, granule, electuary and the pill with known method.
It is little that the prostatitic Chinese medicine for the treatment of of the present invention has toxic and side effects, easy to use and safety.Be applicable to male prostatitis, have blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, tonifying kidney-yin, the effect of eliminating dampness and diuresis.
Be chosen in I patient of institute's treatment and amount to 600 examples, age 35-49 year, year mean age (37.4 ± 5.2), be divided at random treatment group 300 example and matched group 300 examples, treatment group gives Chinese medicine of the present invention and treats, the pervasive Thailand of the control group, tamsulosin hydrochloride and Roxithromycin in treatment, therapeutic effect specifically sees the following form;
| Group | n | Produce effects | Effectively | Invalid | Effective percentage |
| Treatment group | 300 | 248 | 44 | 8 | 97.3％ |
| Matched group | 300 | 156 | 97 | 47 | 84.3％ |
By the table in as can be known, the therapeutic effect for the treatment of group obviously is better than matched group.
Clinical practice example of the present invention is as follows:
Example one:
King xx, man, 34 years old.
First visit: on May 22nd, 2009,, waist abdomen frequent with the discomfort of urinating, chaude-pisse, nocturia aches to examine, poor, the spiritlessness and weakness of companion's sleep, and the sexual life number of times reduces, and quality is unsatisfied with.Examination of prostatic fluid is seen: the lecithin visual field of gathering, conglomerate; Leukocyte +++, color ultrasound is shown: prostatitis companion calcification.Red tongue, yellow fur, wiry forceful pulse.Western medicine diagnose: prostatitis; Tcm diagnosis: smart turbid.The burnt damp-heat type of card subordinate.
The rule for the treatment of: blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, tonifying kidney-yin, eliminating dampness and diuresis.
Use the tablet of Chinese prescription of the present invention to treat, one time 2, every day 2 times, clinical symptoms disappears substantially after 12 days, takes consolidation on the 5th again.
Example two:
Side xx, man, 42 years old.
First visit: examined with frequent micturition, urgent micturition, urethra pain, sagging distention in the smaller abdomen, large dry stool on July 11st, 2009, examination of prostatic fluid is seen: lecithin is a small amount of, leukocyte +++; Color ultrasound is shown: prostatitis companion calcification, red tongue, yellow and greasy fur, stringy pulse.Western medicine diagnose: prostatitis.Tcm diagnosis: smart turbid.The burnt damp-heat type of card subordinate.
The rule for the treatment of: blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, tonifying kidney-yin, eliminating dampness and diuresis.
Use the oral liquid of Chinese prescription of the present invention to treat, one time 1, every day 2 times, clinical symptoms disappears substantially after 10 days.
Example three:
In x, man, 41 years old.
The first visit date: on July 6th, 2010, because " frequent micturition, urgent micturition more than 2 years increased the weight of 10 days " goes to a doctor.The patient is voluntarily oral " SANJIN PIAN ", " paracetamol " once, and symptom is satisfied to my section medical without obvious improvement.Existing disease is seen: frequent micturition, urgent micturition, nocturia 3-5 time has the urine retention sense, the urine line attenuates, companion's soreness of waist pain, whitish discharge from urinary meatus, tending to drink water not, receive sleep can, stool is transferred, and urinates yellow skin, the dark red moist and slippery fur of tongue, stringy and tense pulse.History of past illness: history of drinking history is arranged, guarded against 1 year.EPSRt: leukocyte 2+, lecithin 3+.Diagnosis: Western medicine diagnose-chronic prostatitis; Tcm diagnosis-essence is turbid, and card belongs to damp abundance due to splenic asthenia type.
The rule for the treatment of: blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, tonifying kidney-yin, eliminating dampness and diuresis.
Use the capsule of Chinese prescription of the present invention to treat, one time 2, every day 2 times, 14 days two July in 2010 examined: the patient improves before telling frequent micturition, urgent micturition, urine retention sense, nocturia 2-3 time, lumbago alleviates to some extent, and whitish discharge from urinary meatus disappears, receive sleep can, the light red tongue tongue is white, stringy pulse is slow.
Take medicine after January, in JIUYUE in 2010 further consultation on the 4th, disease is seen frequent micturition, urgent micturition, the urine line is thin obviously improves nocturia 1-2 time.EPSRt: leukocyte 1+, lecithin 4+.
Example four:
Liu, man, 41 years old.
The first visit date: on June 15th, 2011, because " hypogastric region, pubis perineal position pain 8 years increased the weight of 3 months " goes to a doctor.Hypogastric region, pubis perineal position pain appearred in the patient before 8 years, all the time without system's diagnosis and treatment; Before 10 months once oral " QIANLIEKANG ", without positive effect, before 3 months above-mentioned sx↑ and when urinating urethral irritation sense, dampness of scrotum, satisfy to my section medical.Existing disease is seen: hypogastric region, pubis perineal position pain, urethral irritation when urinating, soreness of waist pain, spiritlessness and weakness, the sexual life number of times reduces, erection hardness is poor, can't finish sexual life, receive sleep can, stool is transferred, the partially dim tongue of body of the tongue is little greasy, hesitant pulse.EPSRt: normal.Western medicine diagnose: chronic prostatitis; Tcm diagnosis: smart turbid, card belongs to qi stagnation and blood stasis type.
The rule for the treatment of: blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, tonifying kidney-yin.
Use the granule of Chinese prescription of the present invention to treat, one time 1 bag, every day 2 times,
30 days two July in 2011 examined: the patient tells the rear hypogastric region of taking medicine, pubis perineal position pain, urethral irritation and soreness of waist symptom and all alleviates, and sexual function improves before, the random thoughts spiritlessness and weakness, receive sleep can, stool is transferred, the dimly red tongue tongue is white, weak pulse.Take medicine after February, in JIUYUE in 2011 further consultation on the 9th, all diseases all disappear.EPSRt: normal.
Example five:
Zhang, man, 37 years old, first visit on October 9 in 2011.
The patient begins to occur the burning sensation of urinating because feeling depressed, yellowish urine is red, large dry stool, perineal position and the swollen discomfort of rear urethra pendant or pain, urethral orifice adularescent secretions when urine end or stool, dysphoria, insomnia and dreamful sleep, premature ejaculation was once taken " norfloxacin capsule ", " azithromycin ", " QIANLIEKANG " etc., and effect is not aobvious.History of past illness: history of drinking history is arranged.Examine and see: the burning sensation of urinating, yellowish urine is red, perineal position and the swollen pain of rear urethra pendant, urethral orifice adularescent secretions when urine end or stool; Accompany weak, soreness of the waist and knees, vexed xerostomia, uneasy sleeping at night, large dry stool.Dark tongue quality, yellow and greasy fur, stringy and rolling pulse is strong.EPSRt: leukocyte 3+, lecithin 2+.Diagnosis: Western medicine diagnose: chronic prostatitis; Tcm diagnosis: smart turbid, dialectical is syndrome of dampness-heat in lower jiao;
The rule for the treatment of: blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, tonifying kidney-yin, eliminating dampness and diuresis.
Use the pill of Chinese prescription of the present invention to treat, 1 ball, every day 2 times,
Burning sensation, red, the large dry stool of yellowish urine, the swollen pain of rear urethra pendant of urinating after two weeks and vexed, insomnia take a turn for the better EPSRt: leukocyte 1+, lecithin 3+.Continued to take two months, all diseases of further consultation all disappear after two months, and it is normal that EPSRt recovers.Follow up a case by regular visits to after 1 year and have no special discomfort, have no recurrence.
The invention has the beneficial effects as follows:
The present invention adopts Chinese medicine preparation, toxic and side effects is little, use Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra to be altogether monarch drug, Herba Lycopi, Semen Persicae, Radix Angelicae Sinensis, Radix Rehmanniae, Rhizoma Alismatis are ministerial drug, and Radix Isatidis, Herba Ixeritis chinensis, Herba Taraxaci are adjuvant drug, Fructus Foeniculi is for making medicine, synergism by monarch is brought into play drug effect, has blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, tonifying kidney-yin, the effect of eliminating dampness and diuresis; Curing mainly to be retarded by silt, to swell and ache is few abdomen diseases of primary symptom, and male prostatitis is had very significantly therapeutical effect.
The specific embodiment
In order better to treat male prostatitis, the invention provides a kind of prostatitic Chinese medicine for the treatment of.Next specify in conjunction with the embodiments this and treat prostatitic Chinese medicine.
Embodiment one: oral liquid
21 parts of Radix Salviae Miltiorrhizaes, 14 parts of Radix Paeoniae Rubra, 21 parts of Herba Lycopi, 8 parts in Semen Persicae, 11 parts of Fructus Foeniculi, 20 parts of Radix Angelicae Sinensis, 11 parts of Radix Rehmanniae, 6 parts of Rhizoma Alismatis, 15 parts of Radix Isatidis, 17 parts of Herba Ixeritis chinensiss, 26 parts of Herba Taraxacis;
Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Herba Lycopi, Semen Persicae, Fructus Foeniculi, Radix Angelicae Sinensis, Rhizoma Alismatis, Radix Rehmanniae, Radix Isatidis, Herba Ixeritis chinensis and the Herba Taraxaci 11 flavor medicines of above-mentioned weight proportion are cleaned up, decoct with water twice, each 1 hour, merge decocting liquid twice, filter gained filtrate, be condensed into proportion and be 1.13 clear paste, add water to 1200ml, stirring, is that cold preservation was processed 96 hours under 6 ℃ the condition in temperature, filters, filtrate adds 2 portions of antiseptic and 2 parts of correctivess, then add water to 1200ml, stir, fill is that the oral liquid of 12ml gets final product.
Embodiment two: tablet
18 parts of Radix Salviae Miltiorrhizaes, 16 parts of Radix Paeoniae Rubra, 18 parts of Herba Lycopi, 9 parts in Semen Persicae, 16 parts of Fructus Foeniculi, 17 parts of Radix Angelicae Sinensis, 6 parts of Radix Rehmanniae, 9 parts of Rhizoma Alismatis, 20 parts of Radix Isatidis, 14 parts of Herba Ixeritis chinensiss, 22 parts of Herba Taraxacis.
Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Herba Lycopi, Semen Persicae, Fructus Foeniculi, Radix Angelicae Sinensis, Rhizoma Alismatis, Radix Rehmanniae, Radix Isatidis, Herba Ixeritis chinensis and the Herba Taraxaci 11 flavor medicines of above-mentioned weight proportion are cleaned up, decoct with water twice, add for the first time 8 times of amounts of water, decocted 1.5 hours, add for the second time 6 times of amounts of water, decocted 1 hour, merge decocting liquid twice, filter gained filtrate, be condensed into proportion and be 1.15 clear paste, clear paste is added 90%～95% ethanol, stir, precipitation Recycled ethanol and concentrated, 45～50 ℃ of lower dryings, the dried clear paste of system is for subsequent use.Should do clear paste and be ground into fine powder, add the adjuvant granulation, and dry, and compacting gets final product in flakes.
Embodiment three: capsule
17 parts of Radix Salviae Miltiorrhizaes, 18 parts of Radix Paeoniae Rubra, 12 parts of Herba Lycopi, 15 parts in Semen Persicae, 19 parts of Fructus Foeniculi, 18 parts of Radix Angelicae Sinensis, 8 parts of Radix Rehmanniae, 12 parts of Rhizoma Alismatis, 16 parts of Radix Isatidis, 20 parts of Herba Ixeritis chinensiss, 14 parts of Herba Taraxacis.
Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Herba Lycopi, Semen Persicae, Fructus Foeniculi, Radix Angelicae Sinensis, Rhizoma Alismatis, Radix Rehmanniae, Radix Isatidis, Herba Ixeritis chinensis and the Herba Taraxaci 11 flavor medicines of above-mentioned weight proportion are cleaned up, decoct with water twice, each 1 hour, merge decocting liquid twice, filter gained filtrate, be condensed into proportion and be 1.12 clear paste.This clear paste is added 90%～95% ethanol, stir, precipitate Recycled ethanol and concentrated, dry under 45～50 ℃, it is for subsequent use to make dried clear paste.Should do clear paste and be ground into fine powder, the gelatine capsule of packing into.
Embodiment four: granule
20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Radix Paeoniae Rubra, 12 parts of Herba Lycopi, 14 parts in Semen Persicae, 19 parts of Fructus Foeniculi, 13 parts of Radix Angelicae Sinensis, 8 parts of Radix Rehmanniae, 12 parts of Rhizoma Alismatis, 15 parts of Radix Isatidis, 20 parts of Herba Ixeritis chinensiss, 14 parts of Herba Taraxacis.
Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Herba Lycopi, Semen Persicae, Fructus Foeniculi, Radix Angelicae Sinensis, Rhizoma Alismatis, Radix Rehmanniae, Radix Isatidis, Herba Ixeritis chinensis and the Herba Taraxaci 11 flavor medicines of above-mentioned weight proportion are cleaned up, decoct with water twice, each 1 hour, merge decocting liquid twice, filter gained filtrate, be condensed into proportion and be 1.11 clear paste.Add dextrin, stevioside and appropriate amount of ethanol, mixing, granulation, drying had both got granule.
Embodiment five: electuary
18 parts of Radix Salviae Miltiorrhizaes, 15 parts of Radix Paeoniae Rubra, 15 parts of Herba Lycopi, 14 parts in Semen Persicae, 19 parts of Fructus Foeniculi, 13 parts of Radix Angelicae Sinensis, 8 parts of Radix Rehmanniae, 9 parts of Rhizoma Alismatis, 15 parts of Radix Isatidis, 20 parts of Herba Ixeritis chinensiss, 20 parts of Herba Taraxacis.
Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Herba Lycopi, Semen Persicae, Fructus Foeniculi, Radix Angelicae Sinensis, Rhizoma Alismatis, Radix Rehmanniae, Radix Isatidis, Herba Ixeritis chinensis and the Herba Taraxaci 11 flavor medicines of above-mentioned weight proportion are cleaned up, decoct with water twice, each 1.5 hours, merge decocting liquid twice, filter gained filtrate, be condensed into proportion and be 1.14 clear paste.With this clear paste with 46% ethanol as binding agent, make suitable soft material, this soft material is made wet granular through the YK-160 type oscillating granulator of 12 mesh sieve eyes; This wet granular component is divided, and after the ethanol volatilization was finished, material was put into DPL-30 type Multifunction granulating machine in batches, and drying is about 1 hour in 50 ℃ of boiling driers, and then the final products moisture Control is carried out granulate, packing and namely got electuary in 5%.
Embodiment six: pill
16 parts of Radix Salviae Miltiorrhizaes, 16 parts of Radix Paeoniae Rubra, 15 parts of Herba Lycopi, 12 parts in Semen Persicae, 14 parts of Fructus Foeniculi, 13 parts of Radix Angelicae Sinensis, 12 parts of Radix Rehmanniae, 9 parts of Rhizoma Alismatis, 19 parts of Radix Isatidis, 20 parts of Herba Ixeritis chinensiss, 15 parts of Herba Taraxacis.
Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Herba Lycopi, Semen Persicae, Fructus Foeniculi, Radix Angelicae Sinensis, Rhizoma Alismatis, Radix Rehmanniae, Radix Isatidis, Herba Ixeritis chinensis and the Herba Taraxaci 11 flavor medicines of above-mentioned weight proportion are cleaned up, cleaned raw material is put into drying baker dries, then grind into powder, sieve, the medicamental pulverata that granule is little filters out, for future use.This medicamental pulverata is added refined honey, and ratio is 1: 1, and material is put into the automatic control of ZW-80A type Chinese medicine and become the ball machine to make pill in batches, through selecting ball, and quality inspection, packing gets final product.
More than specific descriptions of the present invention are intended to illustrate the implementation of specific embodiments can not be interpreted as it is limitation of the present invention.Those of ordinary skills can make various variants on the basis of the embodiment that describes in detail under instruction of the present invention, these variants all should be included within the design of the present invention.The present invention's scope required for protection is only limited by described claims.
Claims (4)
1. treat prostatitic Chinese medicine for one kind, the Chinese medicinal components that is comprised of following weight ratio forms:
Radix Salviae Miltiorrhizae 14-26 part, Radix Paeoniae Rubra 9-21 part, Herba Lycopi 9-21 part, Semen Persicae 6-18 part, Fructus Foeniculi 9-21 part, Radix Angelicae Sinensis 9-21 part, Rhizoma Alismatis 3-15 part, the yellow 6-18 part of Radix Rehmanniae, Radix Isatidis 14-26 part, Herba Ixeritis chinensis 14-26 part, Herba Taraxaci 14-26 part.
2. the prostatitic Chinese medicine for the treatment of as claimed in claim 1, the Chinese medicinal components that is comprised of following weight ratio forms:
20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Radix Paeoniae Rubra, 15 parts of Herba Lycopi, 12 parts in Semen Persicae, 15 parts of Fructus Foeniculi, 15 parts of Radix Angelicae Sinensis, 9 parts of Rhizoma Alismatis, yellow 12 parts of Radix Rehmanniae, 20 parts of Radix Isatidis, 20 parts of Herba Ixeritis chinensiss, 20 parts of Herba Taraxacis.
3. the prostatitic Chinese medicine for the treatment of as claimed in claim 2, dosage form comprises tablet, oral liquid, capsule, granule, electuary and pill.
4. such as claim 1 or the prostatitic Chinese medicine of 3 described treatments, dosage form is oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105971563A CN103070995A (en) | 2012-12-30 | 2012-12-30 | Traditional Chinese medicine for curing prostatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105971563A CN103070995A (en) | 2012-12-30 | 2012-12-30 | Traditional Chinese medicine for curing prostatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103070995A true CN103070995A (en) | 2013-05-01 |
Family
ID=48147841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105971563A Pending CN103070995A (en) | 2012-12-30 | 2012-12-30 | Traditional Chinese medicine for curing prostatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103070995A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106860785A (en) * | 2017-03-14 | 2017-06-20 | 肖训 | One kind prevention and the prostatitic Chinese medicine composition for the treatment of |
| KR101895850B1 (en) * | 2017-05-18 | 2018-09-07 | 충남대학교 산학협력단 | Composition for preventing, improving or treating prostate disease comprising extract of Ixeris polycephala as effective component |
| CN114949108A (en) * | 2022-06-20 | 2022-08-30 | 苏州市中医医院 | Traditional Chinese medicine composition for treating prostatitis and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1742903A (en) * | 2005-09-29 | 2006-03-08 | 济南宏济堂制药有限责任公司 | Medicine for treating prostatitis and hyperlasia of prostate |
| CN101015609A (en) * | 2007-03-01 | 2007-08-15 | 济南宏济堂制药有限责任公司 | Application of medicinal composition in preparing medicine for preventing and treating male infertility |
| KR20110057049A (en) * | 2009-11-23 | 2011-05-31 | 박의신 | Functional Prostatitis Therapeutics |
| CN102716184A (en) * | 2012-07-02 | 2012-10-10 | 苏州纳晶医药技术有限公司 | Chinese medicinal composition and application thereof |
-
2012
- 2012-12-30 CN CN2012105971563A patent/CN103070995A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1742903A (en) * | 2005-09-29 | 2006-03-08 | 济南宏济堂制药有限责任公司 | Medicine for treating prostatitis and hyperlasia of prostate |
| CN101015609A (en) * | 2007-03-01 | 2007-08-15 | 济南宏济堂制药有限责任公司 | Application of medicinal composition in preparing medicine for preventing and treating male infertility |
| KR20110057049A (en) * | 2009-11-23 | 2011-05-31 | 박의신 | Functional Prostatitis Therapeutics |
| CN102716184A (en) * | 2012-07-02 | 2012-10-10 | 苏州纳晶医药技术有限公司 | Chinese medicinal composition and application thereof |
Non-Patent Citations (4)
| Title |
|---|
| 容红兵: "中西医结合治疗慢性细菌性前列腺炎45例", 《河南中医》 * |
| 徐发彬等: "通列舒胶囊对大鼠非细菌性前列腺炎模型的影响", 《广州中医药大学学报》 * |
| 曾江林: "中西医结合治疗慢性前列腺炎48例临床观察", 《中医药导报》 * |
| 陈挽澜: "辨证分型为主治疗慢性前列腺炎36例临床观察", 《中医药导报》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106860785A (en) * | 2017-03-14 | 2017-06-20 | 肖训 | One kind prevention and the prostatitic Chinese medicine composition for the treatment of |
| KR101895850B1 (en) * | 2017-05-18 | 2018-09-07 | 충남대학교 산학협력단 | Composition for preventing, improving or treating prostate disease comprising extract of Ixeris polycephala as effective component |
| CN114949108A (en) * | 2022-06-20 | 2022-08-30 | 苏州市中医医院 | Traditional Chinese medicine composition for treating prostatitis and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101884770B (en) | Chinese medicinal preparation for treating urolithiasis and preparation method thereof | |
| CN103721131A (en) | Traditional Chinese medicinal suppository for treating female chronic pelvic inflammation and preparation method thereof | |
| CN105343625A (en) | Taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder and preparation method thereof | |
| CN101869626B (en) | Chinese medicinal compound preparation private care liquid, and preparation and application thereof | |
| CN102526616A (en) | Chinese medicinal herb pills for treating cholecystitis and gallstone | |
| CN104740458A (en) | Pruritus treating traditional Chinese medicine composition | |
| CN104288701A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN101856447A (en) | Capsule capable of clearing heat and purging fire | |
| CN101433655B (en) | Chinese medicinal composition for treating colpitis | |
| CN102526670A (en) | Traditional Chinese medicinal composition for treating cholecystitis and preparation method thereof | |
| CN103070995A (en) | Traditional Chinese medicine for curing prostatitis | |
| CN102526620B (en) | Traditional Chinese medicinal composition for treating gynecological inflammation and application of same | |
| CN105288071A (en) | Traditional Chinese medicine formula used for treatment of hemorrhoid and postoperative nursing and preparation method | |
| CN103127460B (en) | Traditional Chinese medicine composition for curing gynecologic inflammation and preparation method thereof | |
| CN104367946A (en) | Traditional Chinese medicine suppository for treating chronic endometritis and preparation method thereof | |
| CN104225498A (en) | Drug composition for treating primary cold-damp congealing dysmenorrheal and preparation method thereof | |
| CN103656063A (en) | Medicine for treating chronic prostatitis | |
| CN102671021B (en) | Chinese medicament for treating chronic catarrhal otitis media and preparation method | |
| CN105012437A (en) | Traditional Chinese medicine preparation for treating urinary system inflammation and preparation method thereof | |
| CN104707124A (en) | Traditional Chinese medicine preparation for treating chronic endometritis | |
| CN104887933A (en) | Medicine for curing accumulated damp-heat chronic pelvic inflammation | |
| CN105055813A (en) | Traditional Chinese medicine preparation for treating skin itching caused by eczema dermatitis and urticaria | |
| CN104984031A (en) | Traditional Chinese medicine preparation for treating eczema and dermatitis | |
| CN104857127A (en) | Oral administration medicine used for curing accumulated damp heat type chronic pelvic inflammatory disease | |
| CN105477336A (en) | Spleen-strengthening stomach-harmonizing ointment resistant to side effects of chemotherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130501 |